The Effectiveness of Stingless Bee Honey (Kelulut Honey) Versus Gel in Diabetic Wound Bed Preparation
Launched by UNIVERSITI SAINS MALAYSIA · Apr 12, 2021
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female
- • Aged between 18-70 years old
- • Patient with full thickness cavity wound
- • Controlled diabetes mellitus (defined as: fasting blood glucose (FBG) \< 10 mmol/L upon selection)
- Exclusion Criteria:
- • Severely contaminated wound/infected
- • Patient with history of allergy to honey or stingless bee product
- • Patients who are immunocompromised or on chronic steroid use ( defined as use of steroid for more than 2 weeks)
- • Pregnancy
- • End stage renal failure (ESRF) patient
About Universiti Sains Malaysia
Universiti Sains Malaysia (USM) is a leading research university in Malaysia, renowned for its commitment to advancing scientific knowledge and innovation in the healthcare sector. As a clinical trial sponsor, USM leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research aimed at improving patient outcomes and addressing pressing health challenges. The university fosters collaboration among researchers, medical professionals, and industry partners, ensuring that its clinical trials are conducted with the highest ethical standards and scientific integrity. Through its dedication to excellence in research and education, USM plays a pivotal role in shaping the future of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kota Bharu, Kelantan, Malaysia
Patients applied
Trial Officials
Mohamad Aizat Rosli, MB ChB
Principal Investigator
Universiti Sains Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials